AVHHL
AVITA Medical, Inc.
Price Chart
Latest Quote
$0.84
+0.00 (+0.00%)
Current Price
| Previous Close | $0.84 |
| Open | $0.73 |
| Day High | $0.73 |
| Day Low | $0.73 |
| Volume | 150 |
Stock Information
| Shares Outstanding | 153.88M |
| Total Debt | $48.12M |
| Cash Equivalents | $14.26M |
| Revenue | $72.35M |
| Net Income | $-45.34M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $130.03M |
| EPS (TTM) | $-0.31 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $59.87M |
| Sales | $72.35M |
| Income | $-45.34M |
| Book/sh | $-0.75 |
| Cash/sh | $0.09 |
| Employees | 226 |
Financial Ratios
| Quick Ratio | 0.36 |
| Current Ratio | 0.47 |
Returns & Margins
| ROA | -40.78% |
| Gross Margin | 81.36% |
| Operating Margin | -45.73% |
| Profit Margin | -62.67% |
Ownership
| Insider Ownership | 0.14% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 1.80 |
| P/B | -1.12 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.82 |
| SMA50 | $0.86 |
| SMA200 | $0.86 |
| RSI | 31.01 |
| ATR | 0.0276 |
| Shares Float | 30.42M |
| Volatility | 1.90 |
Performance History
| Week | +16.55% |
| Month | -14.82% |
| Quarter | +5.63% |
| 6 Months | +17.85% |
| YTD | +18.51% |
| Year | -40.49% |
| 3 Years | -68.70% |
| 5 Years | -79.39% |
| 10 Years | -47.42% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-03 | $0.85 | 0 |
| 2026-06-02 | $0.85 | 0 |
| 2026-06-01 | $0.85 | 200 |
| 2026-05-29 | $0.73 | 0 |
| 2026-05-28 | $0.73 | 0 |
| 2026-05-27 | $0.73 | 0 |
| 2026-05-26 | $0.73 | 0 |
| 2026-05-22 | $0.73 | 0 |
| 2026-05-21 | $0.73 | 0 |
| 2026-05-20 | $0.73 | 0 |
| 2026-05-19 | $0.73 | 0 |
| 2026-05-18 | $0.73 | 0 |
| 2026-05-15 | $0.73 | 0 |
| 2026-05-14 | $0.73 | 200 |
| 2026-05-13 | $0.99 | 0 |
| 2026-05-12 | $0.99 | 0 |
| 2026-05-11 | $0.99 | 0 |
| 2026-05-08 | $0.99 | 0 |
| 2026-05-07 | $0.99 | 0 |
| 2026-05-06 | $0.99 | 0 |
| 2026-05-05 | $0.99 | 0 |
| 2026-05-04 | $0.99 | 0 |
About AVITA Medical, Inc.
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
đ° Latest News
Undervalued Small Caps With Insider Buying Across Regions
Simply Wall St. âĸ 2026-05-22T11:39:46Z
AVITA Medical, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-15T12:30:00Z
AVITA Medical Inc (AVHHL) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
GuruFocus.com âĸ 2026-05-15T05:02:09ZAvita Medical Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-15T03:05:39Z
Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock?
Zacks âĸ 2026-04-15T11:06:00Z
3 Undervalued Small Caps With Insider Buying Across Regions
Simply Wall St. âĸ 2026-04-14T11:39:59Z
Undervalued Small Caps With Insider Buying To Explore In April 2026
Simply Wall St. âĸ 2026-04-07T11:39:51Z
Exploring 3 Undervalued Small Caps With Insider Buying Across Regions
Simply Wall St. âĸ 2026-03-25T11:39:52Z
Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade
Zacks âĸ 2026-02-25T14:55:02Z
Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know
Zacks âĸ 2026-02-19T17:00:03Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $9,094,000 | $7,780,000 | $6,041,000 | $5,949,000 |
| Cost Of Revenue | $9,094,000 | $7,780,000 | $6,041,000 | $5,949,000 |
| Total Revenue | $64,251,000 | $50,143,000 | $34,421,000 | $29,232,000 |
| Operating Revenue | $64,251,000 | $50,143,000 | $34,421,000 | $29,232,000 |
| Expenses | ||||
| Interest Expense | $5,361,000 | $1,143,000 | $16,000 | $22,000 |
| Total Expenses | $120,844,000 | $92,798,000 | $61,926,000 | $55,772,000 |
| Other Income Expense | $163,000 | $8,483,000 | $892,000 | $17,000 |
| Other Non Operating Income Expenses | $163,000 | $8,483,000 | $892,000 | $17,000 |
| Net Non Operating Interest Income Expense | $-5,361,000 | $-1,143,000 | $-16,000 | $-22,000 |
| Interest Expense Non Operating | $5,361,000 | $1,143,000 | $16,000 | $22,000 |
| Operating Expense | $111,750,000 | $85,018,000 | $55,885,000 | $49,823,000 |
| Selling And Marketing Expense | $58,195,000 | $37,291,000 | $21,913,000 | $14,660,000 |
| General And Administrative Expense | $33,195,000 | $28,334,000 | $23,330,000 | $22,400,000 |
| Other Operating Expenses | - | $-1,428,000 | $-3,215,000 | $-2,055,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-61,845,000 | $-35,381,000 | $-26,665,000 | $-26,583,000 |
| Net Interest Income | $-5,361,000 | $-1,143,000 | $-16,000 | $-22,000 |
| Normalized Income | $-61,845,000 | $-35,381,000 | $-26,665,000 | $-26,583,000 |
| Net Income From Continuing And Discontinued Operation | $-61,845,000 | $-35,381,000 | $-26,665,000 | $-26,583,000 |
| Total Operating Income As Reported | $-56,593,000 | $-42,655,000 | $-27,505,000 | $-26,540,000 |
| Net Income Common Stockholders | $-61,845,000 | $-35,381,000 | $-26,665,000 | $-26,583,000 |
| Net Income | $-61,845,000 | $-35,381,000 | $-26,665,000 | $-26,583,000 |
| Net Income Including Noncontrolling Interests | $-61,845,000 | $-35,381,000 | $-26,665,000 | $-26,583,000 |
| Net Income Continuous Operations | $-61,845,000 | $-35,381,000 | $-26,665,000 | $-26,583,000 |
| Pretax Income | $-61,791,000 | $-35,315,000 | $-26,629,000 | $-26,545,000 |
| Operating Income | $-56,593,000 | $-42,655,000 | $-27,505,000 | $-26,540,000 |
| Gross Profit | $55,157,000 | $42,363,000 | $28,380,000 | $23,283,000 |
| Per Share | ||||
| Diluted EPS | $-0.48 | $-0.28 | $-0.21 | $-0.23 |
| Basic EPS | $-0.48 | $-0.28 | $-0.21 | $-0.23 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-55,304,000 | $-33,540,000 | $-26,045,000 | $-25,808,000 |
| Reconciled Depreciation | $1,126,000 | $632,000 | $568,000 | $715,000 |
| EBITDA (Bullshit earnings) | $-55,304,000 | $-33,540,000 | $-26,045,000 | $-25,808,000 |
| EBIT | $-56,430,000 | $-34,172,000 | $-26,613,000 | $-26,523,000 |
| Diluted Average Shares | $129,415,280 | $126,656,320 | $125,000,900 | $113,371,565 |
| Basic Average Shares | $129,415,280 | $126,656,320 | $125,000,900 | $113,371,565 |
| Diluted NI Availto Com Stockholders | $-61,845,000 | $-35,381,000 | $-26,665,000 | $-26,583,000 |
| Tax Provision | $54,000 | $66,000 | $36,000 | $38,000 |
| Research And Development | $20,360,000 | $20,821,000 | $13,857,000 | $14,818,000 |
| Selling General And Administration | $91,390,000 | $65,625,000 | $45,243,000 | $37,060,000 |
| Other Gand A | $33,195,000 | $28,334,000 | $23,330,000 | $22,400,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,071,000 | $48,569,000 | $84,275,000 | $115,183,000 |
| Total Assets | $79,711,000 | $111,640,000 | $98,264,000 | $125,501,000 |
| Total Non Current Assets | $22,711,000 | $7,634,000 | $10,806,000 | $4,171,000 |
| Other Non Current Assets | $3,552,000 | $2,830,000 | $1,238,000 | $761,000 |
| Goodwill And Other Intangible Assets | $5,570,000 | $487,000 | $465,000 | $472,000 |
| Other Intangible Assets | $5,570,000 | $487,000 | $465,000 | $472,000 |
| Current Assets | $57,000,000 | $104,006,000 | $87,458,000 | $121,330,000 |
| Other Current Assets | $1,883,000 | $1,432,000 | - | - |
| Inventory | $7,269,000 | $5,596,000 | $2,125,000 | $1,647,000 |
| Receivables | $11,963,000 | $7,921,000 | $4,960,000 | $7,883,000 |
| Other Receivables | $177,000 | $257,000 | $1,445,000 | $4,416,000 |
| Accounts Receivable | $11,786,000 | $7,664,000 | $3,515,000 | $3,467,000 |
| Allowance For Doubtful Accounts Receivable | $-71,000,000 | $-48,000,000 | $-24,000,000 | $-30,000,000 |
| Gross Accounts Receivable | $82,786,000 | $55,664,000 | $27,515,000 | $33,467,000 |
| Cash Cash Equivalents And Short Term Investments | $35,885,000 | $89,057,000 | $79,342,000 | $110,746,000 |
| Cash And Cash Equivalents | $14,050,000 | $22,118,000 | $18,164,000 | $110,746,000 |
| Non Current Prepaid Assets | - | $303,000 | $122,000 | $148,000 |
| Investmentin Financial Assets | - | $0 | $6,930,000 | $0 |
| Prepaid Assets | - | $1,414,000 | $1,031,000 | $853,000 |
| Non Current Deferred Assets | - | - | $0 | $613,000 |
| Restricted Cash | - | - | $0 | $201,000 |
| Debt | ||||
| Net Debt | $28,195,000 | $17,694,000 | - | - |
| Total Debt | $45,985,000 | $42,409,000 | $918,000 | $878,000 |
| Long Term Debt And Capital Lease Obligation | $45,085,000 | $41,514,000 | $306,000 | $878,000 |
| Long Term Debt | $42,245,000 | $39,812,000 | - | - |
| Current Debt And Capital Lease Obligation | $900,000 | $895,000 | $612,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $75,212,000 | $62,584,000 | $13,524,000 | $9,846,000 |
| Total Non Current Liabilities Net Minority Interest | $55,054,000 | $49,385,000 | $2,831,000 | $2,456,000 |
| Other Non Current Liabilities | $3,000,000 | - | - | $503,000 |
| Derivative Product Liabilities | $3,432,000 | $3,158,000 | $0 | - |
| Non Current Deferred Liabilities | $3,293,000 | $4,020,000 | $1,968,000 | $1,075,000 |
| Current Liabilities | $20,158,000 | $13,199,000 | $10,693,000 | $7,390,000 |
| Other Current Liabilities | $419,000 | $371,000 | $184,000 | $949,000 |
| Current Deferred Liabilities | $2,094,000 | $168,000 | $272,000 | - |
| Payables And Accrued Expenses | $16,745,000 | $11,765,000 | $9,625,000 | $6,441,000 |
| Payables | $6,294,000 | $3,793,000 | $3,002,000 | $3,120,000 |
| Accounts Payable | $6,294,000 | $3,793,000 | $3,002,000 | $3,120,000 |
| Equity | ||||
| Common Stock Equity | $4,499,000 | $49,056,000 | $84,740,000 | $115,655,000 |
| Total Equity Gross Minority Interest | $4,499,000 | $49,056,000 | $84,740,000 | $115,655,000 |
| Stockholders Equity | $4,499,000 | $49,056,000 | $84,740,000 | $115,655,000 |
| Other Equity Interest | $-1,319,000 | $-1,130,000 | $-127,000 | - |
| Gains Losses Not Affecting Retained Earnings | $-1,939,000 | $-1,887,000 | $7,627,000 | $8,259,000 |
| Other Equity Adjustments | $-1,939,000 | $-1,887,000 | $7,627,000 | $8,259,000 |
| Retained Earnings | $-359,814,000 | $-297,969,000 | $-262,588,000 | $-221,496,000 |
| Preferred Securities Outside Stock Equity | $244,000 | $693,000 | $557,000 | - |
| Other | ||||
| Ordinary Shares Number | $26,354,042 | $25,682,078 | $25,208,436 | $24,895,864 |
| Share Issued | $26,354,042 | $25,682,078 | $25,208,436 | $24,895,864 |
| Tangible Book Value | $-1,071,000 | $48,569,000 | $84,275,000 | $115,183,000 |
| Invested Capital | $46,744,000 | $88,868,000 | $84,740,000 | $115,655,000 |
| Working Capital | $36,842,000 | $90,807,000 | $76,765,000 | $113,940,000 |
| Capital Lease Obligations | $3,740,000 | $2,597,000 | $918,000 | $878,000 |
| Total Capitalization | $46,744,000 | $88,868,000 | $84,740,000 | $115,655,000 |
| Additional Paid In Capital | $367,568,000 | $350,039,000 | $339,825,000 | $328,889,000 |
| Capital Stock | $3,000 | $3,000 | $3,000 | $3,000 |
| Common Stock | $3,000 | $3,000 | $3,000 | $3,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $324,000 | $357,000 | $698,000 | $1,075,000 |
| Long Term Capital Lease Obligation | $2,840,000 | $1,702,000 | $306,000 | $878,000 |
| Current Capital Lease Obligation | $900,000 | $895,000 | $612,000 | - |
| Current Accrued Expenses | $10,451,000 | $7,972,000 | $6,623,000 | $3,321,000 |
| Net PPE | $13,589,000 | $4,317,000 | $2,051,000 | $2,938,000 |
| Accumulated Depreciation | $-3,447,000 | $-2,432,000 | $-2,152,000 | $-1,421,000 |
| Gross PPE | $17,036,000 | $6,749,000 | $4,203,000 | $4,359,000 |
| Leases | $4,607,000 | $367,000 | $257,000 | $242,000 |
| Construction In Progress | $442,000 | $87,000 | $258,000 | $48,000 |
| Other Properties | $8,329,000 | $3,647,000 | $1,623,000 | $2,132,000 |
| Machinery Furniture Equipment | $3,658,000 | $2,648,000 | $2,065,000 | $1,937,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $4,431,000 | $1,035,000 | $610,000 | $424,000 |
| Work In Process | $389,000 | $878,000 | $384,000 | $241,000 |
| Raw Materials | $2,449,000 | $3,683,000 | $1,131,000 | $982,000 |
| Other Short Term Investments | $21,835,000 | $66,939,000 | $61,178,000 | $0 |
| Treasury Shares Number | - | $0 | - | - |
| Current Deferred Revenue | - | $33,000 | $0 | - |
| Investments And Advances | - | $0 | $6,930,000 | $0 |
| Defined Pension Benefit | - | - | $1,238,000 | - |
| Available For Sale Securities | - | - | $6,930,000 | - |
| Other Investments | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-58,272,000 | $-39,458,000 | $-19,615,000 | $-27,075,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-48,939,000 | $-38,011,000 | $-19,090,000 | $-25,901,000 |
| Cash Flow From Continuing Operating Activities | $-48,939,000 | $-38,011,000 | $-19,090,000 | $-25,901,000 |
| Operating Gains Losses | $402,000 | $-8,545,000 | $-82,000 | $358,000 |
| Investing Activities | ||||
| Capital Expenditure | $-9,333,000 | $-1,447,000 | $-525,000 | $-1,174,000 |
| Investing Cash Flow | $37,363,000 | $1,607,000 | $-19,332,000 | $-1,174,000 |
| Cash Flow From Continuing Investing Activities | $37,363,000 | $1,607,000 | $-19,332,000 | $-1,174,000 |
| Financing Activities | ||||
| Financing Cash Flow | $3,508,000 | $40,374,000 | $900,000 | $64,049,000 |
| Cash Flow From Continuing Financing Activities | $3,508,000 | $40,374,000 | $900,000 | $64,049,000 |
| Issuance Of Capital Stock | - | - | $0 | $69,106,000 |
| Net Common Stock Issuance | - | - | $0 | $69,106,000 |
| Common Stock Issuance | - | - | $0 | $69,106,000 |
| Net Other Financing Charges | - | - | - | $-5,109,000 |
| Other | ||||
| Issuance Of Debt | $0 | $38,762,000 | $0 | - |
| Interest Paid Supplemental Data | $5,359,000 | $1,143,000 | $15,000 | $3,000 |
| Income Tax Paid Supplemental Data | $41,000 | $44,000 | $17,000 | $42,000 |
| End Cash Position | $14,050,000 | $22,118,000 | $18,164,000 | $110,947,000 |
| Beginning Cash Position | $22,118,000 | $18,164,000 | $55,712,000 | $73,840,000 |
| Effect Of Exchange Rate Changes | $0 | $-16,000 | $-26,000 | $133,000 |
| Changes In Cash | $-8,068,000 | $3,970,000 | $-37,522,000 | $36,974,000 |
| Proceeds From Stock Option Exercised | $3,508,000 | $1,612,000 | $900,000 | $63,000 |
| Net Issuance Payments Of Debt | $0 | $38,762,000 | $0 | $-11,000 |
| Net Long Term Debt Issuance | $0 | $38,762,000 | $0 | $-11,000 |
| Long Term Debt Issuance | $0 | $38,762,000 | $0 | - |
| Net Investment Purchase And Sale | $46,696,000 | $3,054,000 | $-18,807,000 | $0 |
| Sale Of Investment | $71,200,000 | $81,811,000 | $55,555,000 | - |
| Purchase Of Investment | $-24,504,000 | $-78,757,000 | $-74,362,000 | $0 |
| Net Intangibles Purchase And Sale | $-162,000 | $-66,000 | $-73,000 | $-280,000 |
| Purchase Of Intangibles | $-162,000 | $-66,000 | $-73,000 | $-280,000 |
| Net PPE Purchase And Sale | $-9,171,000 | $-1,381,000 | $-452,000 | $-894,000 |
| Purchase Of PPE | $-9,171,000 | $-1,381,000 | $-452,000 | $-894,000 |
| Change In Working Capital | $-4,678,000 | $-6,574,000 | $-1,196,000 | $-7,356,000 |
| Change In Other Working Capital | $425,000 | $406,000 | $740,000 | $640,000 |
| Change In Other Current Liabilities | $-784,000 | $-447,000 | $-862,000 | $-201,000 |
| Change In Other Current Assets | $-462,000 | $-1,241,000 | $-906,000 | $-889,000 |
| Change In Payables And Accrued Expense | $2,819,000 | $2,156,000 | $1,554,000 | $-840,000 |
| Change In Accrued Expense | $2,479,000 | $1,347,000 | $1,272,000 | $493,000 |
| Change In Payable | $340,000 | $809,000 | $282,000 | $-1,333,000 |
| Change In Account Payable | $340,000 | $809,000 | $282,000 | $-1,333,000 |
| Change In Prepaid Assets | $-345,000 | $-451,000 | $-366,000 | $-342,000 |
| Change In Inventory | $-2,160,000 | $-3,693,000 | $-371,000 | $-745,000 |
| Change In Receivables | $-4,171,000 | $-3,304,000 | $-985,000 | $-4,979,000 |
| Changes In Account Receivables | $-4,145,000 | $-4,172,000 | $-395,000 | $-1,399,000 |
| Other Non Cash Items | $3,708,000 | $4,605,000 | $1,198,000 | $1,289,000 |
| Stock Based Compensation | $13,496,000 | $8,384,000 | $6,998,000 | $5,664,000 |
| Provisionand Write Offof Assets | $23,000 | $24,000 | $-5,000 | $12,000 |
| Asset Impairment Charge | $503,000 | $225,000 | $375,000 | $0 |
| Amortization Of Securities | $-1,674,000 | $-1,381,000 | $-281,000 | $0 |
| Depreciation Amortization Depletion | $1,126,000 | $632,000 | $568,000 | $715,000 |
| Depreciation And Amortization | $1,126,000 | $632,000 | $568,000 | $715,000 |
| Gain Loss On Investment Securities | $274,000 | $750,000 | - | - |
| Net Foreign Currency Exchange Gain Loss | $21,000 | $-9,378,000 | $-85,000 | $228,000 |
| Gain Loss On Sale Of PPE | $107,000 | $83,000 | $3,000 | $130,000 |
| Net Income From Continuing Operations | $-61,845,000 | $-35,381,000 | $-26,665,000 | $-26,583,000 |
| Pension And Employee Benefit Expense | - | $856,000 | $38,000 | - |
| Repayment Of Debt | - | - | $0 | $-11,000 |
| Long Term Debt Payments | - | - | $0 | $-11,000 |
| Deferred Tax | - | - | - | $0 |
| Deferred Income Tax | - | - | - | $0 |
Fetched: 2026-02-02